Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma
Publication Type
Journal Article
Year of Publication
2010
Name of Publication
British journal of cancer
Volume
103
Pagination
52–60